Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Ferric maltol bulk supplier for pharma manufacturers

Ferric Maltol 30 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 30 mg

Reference Brands: Accrufer (USA), Feraccru (EU)

Category: Blood Disorder

Ferric maltol 30 mg capsules are an oral iron for iron-deficiency anaemia, designed to cause fewer stomach side effects than standard iron salts. It is taken twice daily on an empty stomach. Reference brands are Feraccru (EU) and Accrufer (US), made by Shield Therapeutics. Supply is through authorised distribution or named-patient import; ask us which route fits your country.

Ask About Access

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ferric Maltol? List it or send an offer →

Product Description:

Ferric maltol is an oral iron preparation in which ferric iron is complexed with three molecules of maltol, a naturally occurring flavour compound. Conventional oral iron uses ferrous salts, which dissolve freely in the gut and leave unabsorbed iron in the lumen — the cause of the constipation, nausea and black stool that drive discontinuation. The maltol complex is designed to remain intact until absorption, delivering iron with less free iron left behind.

It is indicated for iron deficiency anaemia in adults, and its distinct position is in inflammatory bowel disease, where ferrous salts are poorly tolerated and free luminal iron is an active concern, but intravenous iron means an infusion visit. It offers an oral option for patients who have already failed ferrous sulphate.

Sourcing notes. Originator product, on patent, no generic. Worth noting for buyers that the comparator in trials was placebo or intravenous iron rather than optimally dosed ferrous sulphate, so the tolerability advantage is real but its size against alternate-day low-dose ferrous dosing is not established.

How Ferric Maltol is supplied today, and licensing ahead of patent expiry

Named-patient import Where a patient needs the product in a market where it is not registered, named-patient import is the lawful route. It requires the treating physician's documentation and authorisation from the destination regulator. We handle this pathway. Named-patient access
Authorised distribution For registered markets, supply runs through the manufacturer's authorised distribution channel. We can identify the authorised route for your market and tell you whether the product is registered there at all. Innovator sourcing
A genericised alternative Where the clinical requirement is the drug class rather than this specific molecule, there is often an off-patent alternative that is faster to register and materially cheaper. Tell us the indication and target market and we will say plainly whether one exists. Discuss alternatives
Licensing and generic development Patents expire country by country, and in many countries development and dossier filing can start before expiry under research and regulatory-review exemptions. We connect manufacturers developing this molecule, dossier holders, licensees and tech-transfer partners for markets where it is, or will become, off-patent. Partner on this molecule
Ask about Ferric Maltol supply →
Back to Listing

Frequently Asked Questions


Ferric Maltol is used to treat iron deficiency with or without anemia in adults, particularly in patients who are intolerant of or unresponsive to traditional oral iron salts. It helps restore iron stores, increase hemoglobin levels, and improve symptoms related to iron deficiency.


Ferric Maltol is made from a stable coordination complex of ferric iron (Fe³⁺) and maltol, designed to enhance iron absorption while minimizing gastrointestinal side effects.


The trade names of Ferric Maltol include Accrufer® in the USA and Feraccru® in the EU/UK.


Ferric Maltol is manufactured and marketed by Shield Therapeutics in the EU/UK and by Vifor Pharma / AOP Orphan Pharmaceuticals in the USA.


The generic name is ferric maltol.


The brand names are Accrufer® (USA) and Feraccru® (EU/UK).


Ferric Maltol is manufactured in multiple locations, including the USA and EU, by the respective companies marketing the product in each region.

30 mg twice daily on an empty stomach, for at least 12 weeks in iron-deficiency anaemia.

Adults with iron deficiency, including those with inflammatory bowel disease who cannot tolerate standard oral iron.

No. It is patented and marketed as Feraccru (EU) and Accrufer (US) by Shield Therapeutics.

Ferric Maltol is sold as Accrufer and Feraccru. It is developed and sold by Shield Therapeutics. PharmaTradz handles enquiries for authorised supply of the originator product, named-patient import where it is not registered, and licensing or development work ahead of patent expiry.

Related Products

Anagrelide Hydrochloride

Strength:
0.5 mg, 1 mg

Form: Capsules

Reference Brands: Agrylin (US), Xagrid (EU)

View Details
Lusutrombopag

Strength:
3 mg

Form: Tablets

Reference Brands: Mulpleta (USA), Mulpleo (EU)

View Details
Marstacimab‑Hncq

Strength:
150 mg/mL

Form: injection (prefilled syringe)

Reference Brands: Hympavzi (USA)

View Details
Emicizumab‑Kxwh

Strength:
30 mg/mL, 60 mg/0.4 mL, 105 mg/0.7 mL

Form: Injection

Reference Brands: Hemlibra (USA/EU)

View Details
Deferiprone Tablets

Strength:
250 mg, 500 mg

Form: Tablet

Reference Brands: Ferriprox(US)

View Details
Deferasirox Tablets

Strength:
125 mg, 250 mg, and 500 mg

Form: Tablet

Reference Brands: Exjade(Dispersible tablets);Jadenu (Film-coated Tablet)s

View Details
Daunorubicin Injection

Strength:
20 mg/mL

Form: Intravenous (IV) injection:

Reference Brands: Cerubidine(US)

View Details
Cytarabine Iv/Sq/Intrathecal Injection

Strength:
100 mg/mL(IV & SQ); 50 mg/mL(intrathecal use)

Form: Injection

Reference Brands: DepoCyt(US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us